Durham, NC, United States of America

Richard C Becker


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richard C. Becker: Innovator in Platelet Function Diagnostics

Introduction

Richard C. Becker is a notable inventor based in Durham, North Carolina. He has made significant contributions to the field of medical diagnostics, particularly in the areas of platelet function and antiplatelet therapy. With a total of two patents to his name, Becker's work focuses on improving patient outcomes through innovative diagnostic methods.

Latest Patents

Becker's latest patents revolve around "Diagnostic markers for platelet function and methods of use." These patents disclose biomarkers of platelet function and methods for assessing how patients respond to antiplatelet therapy. By detecting at least one biomarker of platelet function in patients and determining their quantities, these innovations allow for a precise prognosis, diagnosis, or risk identification. Notably, these biomarkers can identify patients as candidates for antiplatelet treatment and facilitate monitoring and adjusting therapy as needed.

Career Highlights

Richard C. Becker is affiliated with Duke University, where he continues to engage in groundbreaking research in the field of medical diagnostics. His contributions serve not only to advance scientific understanding but also to enhance clinical practices for better patient care.

Collaborations

Throughout his career, Becker has collaborated with esteemed colleagues including Geoffrey S. Ginsburg and Joseph E. Lucas. Their joint efforts reflect a commitment to advancing the field of platelet function diagnostics and improving therapeutic strategies for patients requiring antiplatelet therapy.

Conclusion

Richard C. Becker stands out as an influential inventor in the medical diagnostics arena, with patents that are poised to change the way healthcare providers approach platelet function assessment and antiplatelet therapy. His ongoing work at Duke University, combined with his collaborations, reinforces his status as a leader in innovation within the biomedical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…